Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis

A Corrigendum to this article was published on 01 March 2007


Human osteoarthritis is a progressive disease of the joints characterized by degradation of articular cartilage. Although disease initiation may be multifactorial, the cartilage destruction appears to be a result of uncontrolled proteolytic extracellular matrix destruction. A major component of the cartilage extracellular matrix is aggrecan, a proteoglycan that imparts compressive resistance to the tissue. Aggrecan is cleaved at a specific ‘aggrecanase’ site in human osteoarthritic cartilage1,2; this cleavage can be performed by several members of ADAMTS family of metalloproteases3,4,5,6,7,8,9. The relative contribution of individual ADAMTS proteases to cartilage destruction during osteoarthritis has not been resolved. Here we describe experiments with a genetically modified mouse in which the catalytic domain of ADAMTS5 (aggrecanase-2) was deleted. After surgically induced joint instability, there was significant reduction in the severity of cartilage destruction in the ADAMTS5 knockout mice compared with wild-type mice. This is the first report of a single gene deletion capable of abrogating the course of cartilage destruction in an animal model of osteoarthritis. These results demonstrate that ADAMTS5 is the primary ‘aggrecanase’ responsible for aggrecan degradation in a murine model of osteoarthritis, and suggest rational strategies for therapeutic intervention in osteoarthritis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Targeted disruption of the murine ADAMTS5 gene.
Figure 2: Immunohistochemical localization of the aggrecanase-generated TEGE373 neoepitope in growth plates of wild-type, ADAMTS4-/- and ADAMTS5-/- mice.
Figure 3: Histological scores of joints 4 and 8 weeks after induction of joint instability.
Figure 4: Proteoglycan release from articular cartilage from wild-type and ADAMTS5 knockout mice.

Similar content being viewed by others


  1. Sandy, J. D., Flannery, C. R., Neame, P. J. & Lohmander, L. S. The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu373-Ala374 bond of the interglobular domain. J. Clin. Invest. 89, 1512–1516 (1992)

    Article  CAS  Google Scholar 

  2. Lohmander, L. S., Neame, P. J. & Sandy, J. D. The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. Arthritis Rheum. 36, 1214–1222 (1993)

    Article  CAS  Google Scholar 

  3. Kuno, K. et al. ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan. FEBS Lett. 478, 241–245 (2000)

    Article  CAS  Google Scholar 

  4. Rodríquez-Manzaneque, J. C. et al. ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors. Biochem. Biophys. Res. Commun. 293, 501–508 (2002)

    Article  Google Scholar 

  5. Somerville, R. P. T. et al. Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1. J. Biol. Chem. 278, 9503–9513 (2003)

    Article  CAS  Google Scholar 

  6. Collins-Racie, L. A. et al. ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage. Matrix Biol. 23, 219–230 (2004)

    Article  CAS  Google Scholar 

  7. Yamaji, N. et al. Metalloprotease having aggrecanase activity. US patent 6,716,613 (2004).

  8. Tortorella, M. D. et al. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 284, 1664–1666 (1999)

    Article  ADS  CAS  Google Scholar 

  9. Abbaszade, I. et al. Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J. Biol. Chem. 274, 23443–23450 (1999)

    Article  CAS  Google Scholar 

  10. Sandy, J. D., Neame, P. J., Boynton, R. E. & Flannery, C. R. Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain. J. Biol. Chem. 266, 8683–8685 (1991)

    CAS  PubMed  Google Scholar 

  11. Glasson, S. S. et al. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knock out mice. Arthritis Rheum. 50, 2547–2558 (2004)

    Article  CAS  Google Scholar 

  12. Chambers, M. G. et al. Matrix metalloproteinases and aggrecanases cleave aggrecan in different zones of normal cartilage but colocalize in the development of osteoarthritic lesions in STR/ort mice. Arthritis Rheum. 44, 1455–1465 (2001)

    Article  CAS  Google Scholar 

  13. Clements, K. M. et al. Gene deletion of either interleukin-1β, interleukin-1β-converting enzyme, inducible nitric oxide synthase or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy. Arthritis Rheum. 48, 3452–3463 (2003)

    Article  CAS  Google Scholar 

  14. Little, C. B., Meeker, C. T. & Fosang, A. J. Degradative mechanisms in mouse articular cartilage: use of in vitro models to analyse proteolysis and loss of aggrecan and link protein. Trans. Orthop. Res. Soc. 28, 699 (2003)

    Google Scholar 

  15. Farndale, R. W., Buttle, D. J. & Barrett, A. J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim. Biophys. Acta 883, 173–177 (1986)

    Article  CAS  Google Scholar 

  16. Hughes, C. E., Little, C. B. & Caterson, B. Measurement of aggrecanase-generated interglobular domain catabolites in the medium and extracts of cartilage explants using Western blot analysis. Methods Mol. Biol. 225, 89–98 (2003)

    CAS  PubMed  Google Scholar 

Download references


The authors would like to acknowledge M. Jin and X.-Y. Tan for generation of the monoclonal antibody AGG-C1. We also acknowledge the assistance of W. Kuang, M. Liang, K. Shih, J. Tavares, K. Tomkinson and T. Crawford, and the Bioresources staff at Wyeth.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Elisabeth A. Morris.

Ethics declarations

Competing interests

The authors declare that they have no competing financial interests.

Supplementary information

Supplementary Data

This file contains Supplementary Methods, Supplementary Results 1-4 and also contains additional references. (DOC 26 kb)

Supplementary Figures S1-S3

This file contains Supplementary Figures S1-S3 and their accompanying legends. (PDF 348 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Glasson, S., Askew, R., Sheppard, B. et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434, 644–648 (2005).

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI:

This article is cited by


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing